Neadjuvant Multi-agent Chemotherapy or Letrozole Plus Ribociclib in Luminal B/HER2-negative Breast Cancer.
Clinical trial NCT03248427 · COMPLETED
Trial details
- NCT number
- NCT03248427
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-13
- Primary completion
- 2019-06-10
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.